Disclaimer: this is not an investment site. Do not make any investment, financial, job, career, travel, or relationship decisions based on what you read here or think you may have read here.
Link here. From early August, 2020, last year:
- CureVac doesn't rule out accelerated approval for Covid-19 vaccine; interesting, interesting story; connecting the dots;
- German biotechnology firm
- expects to put its vaccine on the market in mid-2021
- CureVac: backed by Bill Gates
- CureVac: listed ont eh NASDAQ three days ago, Friday, August 14, 2020, raising $213 million;
- ticker symbol: CVAC
- closing price on first day of trading: $55.90; up 250%)
First day of trading, back in early August, 2020:
From August 8, 2020:
CureVac: of the thousands of sticker symbols I could have chosen, back on August 14, 2020, I chose CureVac (CVAC) trading up 250% on its first day of trading; closed at $56. Today, I see CVAC is up another $15, up almost 14% today; and closed at $130. Moderna had a great day. This is clearly not rocket science. PFE. JNJ.
Fast forward, today, June 17, 2021: CureVac plummeting. Over at The WSJ, "CureVac sharees plunge premarket on disappointing Covid-19 vaccine trial. Vaccine was 47% effective in an analysis of a trials, says the company, which attributed the poor performance to variants.
Not even mentioned on CNBC this morning. Makes sense: Bill Gates and MSNBC --> CNBC joined at the hips.
For its main listing in the U.S., shares were down 45% in off-hours trading. Shares in the company listed in Frankfurt traded 43% lower Thursday.
No comments:
Post a Comment